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Sumrrlary 
Recent crystallographic studies on two peptide complexes with the mouse K b molecule have 
shown that peptide binding appears to alter the conformation of the class I or-helical regions 
that flank the antigen binding cleft. Given that this study also showed that much of the foreign 
peptide is buried within the class I binding cleft with only a small portion accessible for direct 
interaction with the components of the T cell receptor,  this finding suggests that at least some 
component of T  cell specificity may arise as a consequence of peptide-induced conformational 
changes in the class I structure. To assess this possibility, we have made systematic substitutions 
at residues within the Kb-restricted determinant from ovalbumin (OVA257-264) that are thought 
to be buried on binding to the class I molecule. We have found that changes in this determinant 
at the completely buried second residue (P2) can influence T cell recognition without affecting 
binding to K b, suggesting that the substitutions may indirectly determine T  cell recognition 
by altering the conformation of the class I molecule or the bound peptide. 
T 
he products of the MHC class 1 loci bind small peptides 
derived from cytoplasmic degradation of foreign and self 
proteins (1-2). Such complexes are recognized by the antigen- 
specific receptors on the surface of CD8 + T cells, triggering 
their peripheral activation and their initial selection within 
the thymus (3, 4). Allelic variations  at pockets within the 
antigen binding cleft are thought to result in selective binding 
of peptide fragments that bear the correct motif amino acid 
sidechains to anchor and stabilize peptide-MHC association 
(5-10). The more exposed sidechains of the nonanchor amino 
acids would then be free to directly contact the TCR and 
determine T cell recognition (7, 9). Whereas the recent crys- 
taUographic analysis of two complexes between viral peptides 
and the mouse K b molecule by Fremont et al. (9) revealed 
that the central region of the bound peptide fragments were 
particularly  exposed for  potential TCR  recognition,  the 
majority of the peptide antigen remained buried within the 
class I binding cleft. These workers speculated that given the 
limited extent of peptide exposure and the homology of TCR 
polypeptides to the Fab fragment of antibodies (11-14),  T 
cell recognition would necessitate interactions over a relatively 
large surface area probably incorporating sizable regions of 
the MHC class I molecule itself. Furthermore, since the two 
peptide complexes chosen for study revealed the existence of 
peptide-induced conformational changes within the class I 
structure, this raises the possibility that peptide-dependent 
alteration in class I may play a critical  role in determining 
TCR recognition (9). 
In an effort to assess what role such conformational changes 
might have on T cell recognition, we have made alterations 
at residues within the Kb-restricted determinant from OVA, 
SIINFEKL  (OVA2sy-264) (15, 16)  that  are  expected to be 
completely buried within the class I binding cleft (10). We 
reasoned that modulation of T cell recognition by substitu- 
tions at buried residues would identify the influence of in- 
direct conformational changes. 
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Cell  Lines  and  Synthetic  Peptides.  The  Kb-restricted, OVA- 
specific CD8 § T cell hybridomas B3.1 and GA4.2 have been de- 
scribed previously (17), and 149.13.13 and 149.42.12 CD8 + T ceil 
hybridomas were derived from a TCR B chain transgenic mouse 
expressing the TCR./~ chain from B3.1 (17). 5A.K  s is an L cell 
transfectant expressing the K  s gene (18), whereas RMA-S is an 
H-2  b antigen presentation-defective cell line that expresses low 
surface levels of class I molecules devoid of endogenous peptides 
(19, 20). Synthetic analogs of the octomeric OVA257-264 deter- 
minant substituted at the peptide positions 2, 5, and 8 (P2, PS, 
and P8) with various natural amino acids were synthesized  by the 
Multipin Synthesis  System  (Chiton Mimotopes, Clayton, Australia) 
with free NH2 and COOH termini (21). 
T Cell Hybridoma Assays.  T call hybridoma stimulation by the 
Kb-presented peptides was assessed by quantitating  the antigen- 
specific release of I1-2. 50/d of complete DME media with 10% 
FCS containing 4  x  104 5A.K  b cells were aliquoted into each well 
of  a 96-well flat-bottomed plate (Costar, Cambridge, MA) and the 
cells allowed to adhere by overnight incubation. At the end of this 
time, synthetic peptides were added to the appropriate wells to give 
a final concentration of 10 -s M. After incubation for I h at 37~ 
the plate was washed three times with 200/xl of DME media fol- 
lowed by the addition of 200/xl suspension of the T cell hybrid- 
omas (105 cells) in DME media with 10% FCS. After a 24-h in- 
cubation  at  37~  in  6.5%  COz,  50  #1  of supernatant  was 
collected and the I1-2 content measured using the indicator cell 
line CTLL by a colorimetric  assay  employing  3-(4,5-dimethykhiazol- 
2-yl)-2,5-diphenyltetrazolium  bromide (MTT) (22). Activation  was 
measured at ODs70. 
Assay for Petnide Binding to K b.  Relative  peptide binding was 
assessed by measuring the folding and stabilization of K  s on the 
surface of RMA-S cells after culture in media containing the ap- 
propriate peptides (19, 20). RMA-S cells 0  x  105) were incubated 
for 12-14 h in 400/~1 of complete DME media with 10% FCS 
and various dilutions of the peptide analogs in 24-weil plates. The 
cells were then harvested and stained using the Kb-specific anti- 
body Y3 (23) and a fluoresceinated  anti-mouse antibody (Silenus 
Laboratories, Hawthorn, Vic., Australia) before flow cytometry 
using a FACScan  |  (Becton Dickinson & Co., Sunnyviile,  CA). Pep- 
tide binding to K  s is proportional to the observed increase in mean 
fluorescence  and demonstrated  highly reproducible saturable binding 
characteristics. 
Results and Discussion 
Falk et al. (6) sequenced a mixture of natural peptides bound 
to K  b and found that they had a preferred length of eight 
amino acids with motif residues of Leu at peptide position 
8 (P8) and Phe or Tyr at PS. Shibata et al. (24) have shown 
that these residues are critical for interaction with K b since 
Ala substitutions at the P5 and P8 anchor residues in a vesic- 
ular stomatitis virus nudeoprotein (VSV NP) peptide prevented 
K b binding. The crystal structure of the VSV  NP peptide 
complexed with K ~ confirms that the P5 and P8 sidechains 
are completely buried in deep pockets within the K  b antigen 
binding site (9). In addition, the structure of this peptide-class 
I complex and that involving the Kb-restricted Sendai virus 
nudeoprotein (SV NP) determinant predict that the nonmotif 
P2 sidechain for Kb-bound peptides should also be buried 
within the antigen binding site and consequently be inacces- 
sible for direct T  cell interaction (10). 
We have extended the previous studies of Shibata et al. (24) 
to the OVAz57-~4, Kb-restricted determinant and substituted 
each of the buried residues at P2, PS, and P8 with 16 other 
natural amino acids. The ability of the analogs to stimulate 
four CD8 +  OVA-specific T  cell  hybridomas is  shown ila 
Fig. 1. Substitutions of the P8 Leu from OVA257-~ with the 
conserved amino acids of Ile and Val to give the 8I and 8V 
analogs, respectively, do not appreciably  affect T cell recog- 
nition. The less conserved substitutions of Ala or Gly at the 
P8 residue (8A or 8G) attenuate or abolish the potency of 
these peptide analogs.  All four T  cell hybrids have similar 
reactivity to these analogs, showing a reduced but reproduc- 
ible response to stimulation by 8A and no response  to 8G. 
Association  of K b with peptide results in the increased ex- 
pression of K  b on the surface of the processing-defective mu- 
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Figure 1.  T cell  hybridoma  reactivity  with P2, PS, and P8 peptide  sub- 
stitutions of the OVA determinant. 5A.K  b APCs were pulsed with 
10- s M of OVA2s7-~s4 (SIINFEKL)  (*) or synthetic  peptide analogs sub- 
stituted at P2 (a), P5 (b), and P8 (c) before the addition  of the T cell hy- 
bridomas B3.1, GA4.2, 149.13.13, and 149.42.12. II-2 secretion  by the ac- 
tivated T cells was measured  using the I1-2-dependent cell line CTLL  in 
a colorimetric assay, and is expressed at OD570. 
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pression induced by the various peptide analogs can be used 
to quantitate this binding. The results in Fig. 2 demonstrate 
that substituting the P8 Leu in OVA2sT-264 with a Val or lie 
has little or no effect on peptide binding to K s. In contrast, 
the Ala, and in particular the Gly P8 substitutions, attenuate 
this binding considerably. Thus, the combined T cell stimu- 
lation and K b binding data demonstrate that changes at P8 
appear to affect T  cell stimulation by reducing the ability 
of the peptide determinant to bind to K b. 
The data for the P5 substitutions essentially mirrors that 
found for the P8 substitutions. The 5Y analog stimulates the 
four OVA2sT-2c,4-specific  T cell hybrids, whereas substitutions 
containing the nonconserved Ala or Gly at P5 fail to do so. 
It is surprising that 5Y is only marginally better at binding 
K b than 5A (Fig. 2). More significantly, 5V associates more 
efficiently with K b than the more potent T  cell stimulator 
8 
O 
o~ 
o~ 
1200 
800 
400 
I 
o 
a 
OVA257-264 
2G 
2F 
.  2Y 
10-11  10-10 10-9 10-8 10-7 10-6 10-5 
b  OVA257-264 
5Y 
6A 
5G 
Y 
0-~// ...............  ........ 
10  -11  10  -10  10  -9 10  .8  10  .7  10.8  10  .6 
1200 
800 
400 
C  OVA257-264 
gv 
8A 
8G 
10-11 10-10  10-9 10.8  10-  7  10-6 10-5 
Peptide-concentration  (M) 
Figure  2.  Peptide-induced stabilization of Kb-expression on the surface 
of the presentation defective cell line RMA-S. The presentation-defective 
cell line RMA-S  was  incubated with  increasing concentrations  of the 
OVA2sr  (SIINFEKL)  (0) or synthetic analogs substituted at P2 (a), 
P5 (b), and P8 (c) with residues Ala (I),  Gly ([2]), Ile (X), Phe (A), Tyr 
(O),  or Val (&).  The increase in K b expression was measured by flow 
cytometry after staining using the Kb-specific antibody Y3,  and is ex- 
pressed as a mean channel fluorescence. 
5Y. Whereas the four T  cell hybrids did not recognize 5V 
at the 10 -s M  peptide concentration used in Fig.  1,  they 
could all be activated by 10- # M concentrations of this pep- 
tide (data not shown). The results suggest that whereas sub- 
stitutions at P5 in the OVAzsT-~ peptide primarily influence 
peptide binding to K b, they also have an indirect effect on 
T  cell recognition. 
This indirect effect on T cell stimulation is more pronounced 
for the P2 substitutions of the OVA2sT-z64 peptide. Whereas 
2A, 2G, and the parental OVA2s7-2ea show similar binding 
to K b (Fig. 2), they have different potencies for T cell stim- 
ulation (Fig.  1).  Crystallographic studies have shown that 
P2 is completely buried in the K b complexes with the VSV 
NP peptide (Gly at P2), and the SV NP peptide (Ala at P2) 
(9). The four T cell hybrids used in our studies show a different 
fine specificity for the analogs with Ala and Gly substitu- 
tions at P2.  For example, the B3.1,  GA4.2,  and 149.13.13 
hybrids recognize 2G, whereas 149.42.12  fails to do so. In 
contrast, GA4.2,  149.13.13,  and 149.42.12  respond to 2A, 
whereas B3.1 does not. Although Fig. 2 shows that the Ala 
and Gly substitutions at P2 do not disrupt peptide binding 
to  K b,  certain  substitutions  at  P2  can  affect peptide-K  b 
affinity as evidenced by the poor binding of the 2F and 2Y 
analogs. This confirms that P2 in the Kb-bound determinant 
is buried within the class I binding deft, as proposed by Mat- 
zumura et al. (10). Whereas this also implies that P2 is im- 
portant in peptide-MHC interactions, our data showing K b 
presentation (Fig.  1) and binding (Fig.  2) by analogs with 
divergent P2 substitutions would suggest that it is not a major 
anchor residue such as P5 or P8. This is consistent with the 
finding that P2 was not identified as a motif position for K b- 
bound peptides (6). The ability of analogs with diverse sub- 
stitutions such as 2N, 2S, and 2T to stimulate OVA-specific 
T cells in a clone-specific manner (Fig. 1) would further sug- 
gest that P2 sidechains are unlikely to directly contact TCR. 
Nonetheless, changes at this position appear to influence T 
cell recognition. We would argue that this results from con- 
formational alterations at other more exposed parts of the 
peptide or at regions of the MHC that are in direct contact 
with the TCR. 
The upper surfaces of the class I oe-helices are thought to 
directly contact the TCR (25) and are likely to play an im- 
portant role during positive selection, possibly determining 
the requirement for self restriction. Our results show that 
changes at peptide residues buried within deep pockets could 
indirectly alter TCR interaction with class I.  It is possible 
that corresponding allele-specific changes at these same class 
I pockets could also result in a similar effect and explain how 
such variation at sites buried in the class I cleft can influence 
self restriction (3, 4). For example, the P2 sidechains for K b- 
restricted peptides bind at a completely buried pocket within 
the class I antigen-binding cleft lined by amino acids 9, 24, 
45,  and 67 (pocket B in reference 10). A variant of the K b 
molecule with changes at this site, K bins is known to abolish 
the thymic selection of Kb-restricted T cells specific for the 
OVA2s7-264 determinant without  affecting selection for T 
cells specific for the VSV NP determinant (3). This differen- 
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differences in binding affinity  for particular selecting self  pep- 
tides. Alternatively, differences in positive selection between 
K  b and K b~s might arise as a result of constraints imposed 
by P2 interaction with pocket B resulting in class I confor- 
mation changes. Peptide-specific alteration in the class I con- 
formation could therefore play a dominant role in T cell rec- 
ognition during T cell activation and, more importantly, in 
the selection for self restriction during the thymic matura- 
tion process. 
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